Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash at Brea Canyon and Tonner Canyon Roads


2 Vehicles Collide in Fatal Brea Accident 

Brea, CA (March 20, 2020) – One person was killed in a crash in Brea. The fatal accident occurred on the morning of March 20 at Brea Canyon and Tonner Canyon roads.

A Nissan van and a Honda Civic collided at the intersection. One person died at the accident scene. It is unknown if anyone was injured.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Brea

#92821


December 9, 2019

Donald Sanders Killed in Crash at South Rancho Avenue and West N Street

Several Vehicles Involved in Fatal Colton Accident ...


May 20, 2020

Pedestrian Killed in Crash on Highway 273 Near Buenaventura Boulevard

Car Hits Woman in Fatal Redding Accident ...


March 24, 2020

1 Injured in Crash on Highway 52 Between Santo Road and Mast Boulevard

4 Vehicles Involved in San Diego Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.